Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2012

Study Completion Date

May 16, 2016

Conditions
Lung Cancer
Interventions
DRUG

Induction Carboplatin

DRUG

Induction Paclitaxel

PROCEDURE

Resection

DRUG

Consolidation Carboplatin

RADIATION

Radiation Therapy

DRUG

Consolidation Paclitaxel

Trial Locations (22)

18015

St. Luke's Cancer Network at St. Luke's Hospital, Bethlehem

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

26003

Schiffler Cancer Center at Wheeling Hospital, Wheeling

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

32224

Mayo Clinic - Jacksonville, Jacksonville

32308

Tallahassee Memorial Hospital, Tallahassee

37662

Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center, Kingsport

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

53226

Medical College of Wisconsin Cancer Center, Milwaukee

53295

Veterans Affairs Medical Center - Milwaukee, Milwaukee

55905

Mayo Clinic Cancer Center, Rochester

62702

Cancer Institute at St. John's Hospital, Springfield

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

68114

Methodist Estabrook Cancer Center, Omaha

85013

Arizona Oncology Services Foundation, Phoenix

85260

Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Scottsdale

90089-9181

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

48106-0995

Saint Joseph Mercy Cancer Center, Ann Arbor

08103

Cancer Institute of New Jersey at Cooper University Hospital - Camden, Camden

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

27835-6028

Leo W. Jenkins Cancer Center at ECU Medical School, Greenville

54307-3508

St. Vincent Hospital Regional Cancer Center, Green Bay

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Radiation Therapy Oncology Group

NETWORK

NCT00096226 - Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter